Methyllycaconitine
CAS: 21019-30-7
Ref. 3D-XM183142
5mg | 453,00 € | ||
10mg | 647,00 € | ||
25mg | 1.160,00 € | ||
50mg | 1.739,00 € | ||
100mg | 2.319,00 € |
Produktinformation
- (1α,6β,14α,16β)-20-Ethyl-1,6,14,16-tetramethoxy-4-[[[2-[(3S)-3-methyl-2,5-dioxo-1-pyrrolidinyl]benzoyl]oxy]methyl]aconitane-7,8-diol
- Aconitane-7,8-diol, 20-ethyl-1,6,14,16-tetramethoxy-4-(((2-(3-methyl-2,5-dioxo-1-pyrrolidinyl)benzoyl)oxy)methyl)-, (1alpha,4(S),6beta,14alpha,16beta)-
- Aconitane-7,8-diol, 20-ethyl-1,6,14,16-tetramethoxy-4-[[[2-(3-methyl-2,5-dioxo-1-pyrrolidinyl)benzoyl]oxy]methyl]-, [1α,4(S),6β,14α,16β]-
- Aconitane-7,8-diol, 20-ethyl-1,6,14,16-tetramethoxy-4-[[[2-[(3S)-3-methyl-2,5-dioxo-1-pyrrolidinyl]benzoyl]oxy]methyl]-, (1α,6β,14α,16β)-
- Aconitane-7,8-diol, 20-ethyl-4-(((2-(3-methyl-2,5-dioxo-1-pyrrolidinyl)benzoyl)oxy)methyl)-1,6,14,16-tetramethoxy-, (1-alpha,4(S),6-beta,14-alpha,16-beta)-
- Brn 0076234
- Delartine
- Delsemidine
- Lycaconitine, methyl-
- [(1alpha,6beta,10alpha,13xi,14alpha,16beta,17xi)-20-ethyl-7,8-dihydroxy-1,6,14,16-tetramethoxyaconitan-4-yl]methyl 2-[(3S)-3-methyl-2,5-dioxopyrrolidin-1-yl]benzoate
- Mehr Synonyme anzeigen
- [(6Beta,14Alpha,16Beta,17Xi)-20-Ethyl-7,8-Dihydroxy-1,6,14,16-Tetramethoxyaconitan-4-Yl]Methyl 2-(3-Methyl-2,5-Dioxopyrrolidin-1-Yl)Benzoate
- [(6Beta,7Beta,13Xi,16Beta)-20-Ethyl-7,8-Dihydroxy-1,6,14,16-Tetramethoxyaconitan-4-Yl]Methyl 2-(3-Methyl-2,5-Dioxopyrrolidin-1-Yl)Benzoate
Methyllycaconitine is a potent inhibitor of kinases, making it a valuable medicinal compound for the treatment of various diseases. It has been shown to induce apoptosis in tumor cells and inhibit the growth of cancer cells in humans. Methyllycaconitine is an analog of lycaconitine, which is a toxic alkaloid found in Chinese herbal medicine. This compound has anticancer properties that make it a promising candidate for the development of new cancer therapies. Its ability to selectively target protein kinases involved in cancer cell growth and survival makes it a valuable tool for cancer research and drug discovery. In addition, methyllycaconitine has shown potential as an inhibitor of urinary bladder contractions, making it useful for treating related disorders.
Chemische Eigenschaften
Technische Anfrage zu: 3D-XM183142 Methyllycaconitine
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.